Relationship of <i>BMPR2</i> Mutations to Vasoreactivity in Pulmonary Arterial Hypertension

Abstract

Patients with familial or idiopathic PAH and nonsynonymous BMPR2 variations are unlikely to demonstrate vasoreactivity. Further trials are required to determine whether long-term therapy can be directed by tests for BMPR2 variations.